Increased circulating transforming growth factor β1 in a patient with giant hepatic hemangioma: Possible contribution to an impaired immune function
N. Ito, S. Kawata, H. Tsushima, S. Tamura, S. Kiso, S. Takami, T. Igura, M. Monnden, Y. Matsuzawa – 30 December 2003 – A patient, having a huge hepatic hemangioma, presented with decreases in the number of peripheral lymphocytes and in serum concentrations of γ‐globulin and immunoglobulin (Ig) G, and a negative purified protein derivatives skin test, indicating that the patient's immunity was impaired. The plasma concentration of transforming growth factor β1 (TGF‐β1), a potent immunosuppressor, in the patient was markedly elevated (113 ng/mL, normal < 5).